Performance Characteristics of the New Definition of Diabetes - The Insulin Resistance Atherosclerosis Study

被引:41
作者
Lorenzo, Carlos [1 ]
Haffner, Steven M. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
关键词
CARDIOVASCULAR-DISEASE; ALL-CAUSE; GLUCOSE; MORTALITY; HYPERGLYCEMIA; GLYCEMIA; OBESITY;
D O I
10.2337/dc09-1357
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- A1C >= 6.5% has been recently proposed as the defining criterion for diabetes. However, performance characteristics of this definition have not been described. RESEARCH DESIGN AND METHODS - in the Insulin Resistance Atherosclerosis Study, we compared new to previous definitions of diabetes: 1999 World Health Organization (DM1999WHO) and 2003 American Diabetes Association based on fasting glucose alone (DMFPG126). RESULTS - Participants with A1C >=-6.5%, DM1999WHO and DMFPG126 were 44 (5.2%),1.32 (15.4%), and 61 (7.1%), respectively. In individuals With DM1999WHO, mean, median, and interquartile range of A1C were 6.3, 5.9, and 5.5-6.6%, respectively; in individuals with DMFPG126, mean, median, and iraerquartile range of A1C were 7.0, 6.6, and 6.0-7.1%. CONCLUSIONS- A1C >= 6.5% identifies fewer individuals than DM1999WHO or DMFPG126 Studies are needed to determine that A1C >= 6.5% compromises neither blood pressure and lipid management in early diabetes nor the implementation of lifestyle interventions for diabetes prevention.
引用
收藏
页码:335 / 337
页数:3
相关论文
共 15 条
[1]  
[Anonymous], DEF DIAGN CLASS DIAB
[2]   Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study [J].
Barr, E. L. M. ;
Boyko, E. J. ;
Zimmet, P. Z. ;
Wolfe, R. ;
Tonkin, A. M. ;
Shaw, J. E. .
DIABETOLOGIA, 2009, 52 (03) :415-424
[3]   Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population:: the Hoorn Study [J].
de Vegt, F ;
Dekker, JM ;
Ruhé, HG ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
DIABETOLOGIA, 1999, 42 (08) :926-931
[4]   From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus [J].
DeFronzo, Ralph A. .
DIABETES, 2009, 58 (04) :773-795
[5]  
Gavin JR, 1999, DIABETES CARE, V22, pS5
[6]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[7]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403
[8]   Fasting and postchallenge glycemia and cardiovascular disease risk - The framingham offspring study [J].
Meigs, JB ;
Nathan, DM ;
D'Agostino, RB ;
Wilson, PWF .
DIABETES CARE, 2002, 25 (10) :1845-1850
[9]   International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes [J].
Nathan, David M. ;
Nathan, David M. ;
Balkau, Beverly ;
Bonora, Enzo ;
Borch-Johnsen, Knut ;
Buse, John B. ;
Colagiuri, Stephen ;
Davidson, Mayer B. ;
DeFronzo, Ralph ;
Genuth, Saul ;
Holman, Rury R. ;
Ji, Linong ;
Kirkman, Sue ;
Knowler, William C. ;
Schatz, Desmond ;
Shaw, Jonathan ;
Sobngwi, Eugene ;
Steffes, Michael ;
Vaccaro, Olga ;
Wareham, Nick ;
Zinman, Bernard ;
Kahn, Richard .
DIABETES CARE, 2009, 32 (07) :1327-1334
[10]   GHb is a better predictor at cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes - The Rancho Bernardo Study [J].
Park, S ;
BarrettConnor, E ;
Wingard, DL ;
Shan, J ;
Edelstein, S .
DIABETES CARE, 1996, 19 (05) :450-456